Sort
21,281 grants matching “influenza”
Early Immune Development and Function in Neonates Exposed to Maternal HIV Infection
$508,514Huanbin Xu · Tulane University Of Louisiana · R01 · FY2019 · AI
Fc effector function in bNAbs
$508,500Jeffrey Victor Ravetch · California Institute Of Technology · P01 · FY2017 · AI
Skeletal Muscle Loss and Dysfunction
$508,328Nathan K Lebrasseur · Mayo Clinic Rochester · P01 · FY2023 · AG
Single cell molecular analysis of influenza vaccine responses in elderly individuals
$508,278Spyros A Kalams · Vanderbilt University Medical Center · R01 · FY2020 · AI
Deciphering long-term virus evolution through the reconstruction of past viral genomes
$508,271Daniel Blanco-Melo · Fred Hutchinson Cancer Center · DP2 · FY2025 · AI
Using a Telehealth Model to Address Vaccine Hesitancy and Increase Vaccine Completion Among Communities in Southeastern Louisiana
$508,254Sara Abdul Sattar Al-Dahir · Xavier University Of Louisiana · U54 · FY2024 · MD
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination
$508,137Mark M Davis · Stanford University · U19 · FY2017 · AI
Influenza & COVID Obstetric and Perinatal Epidemiology Study in India
$508,025Patricia L Hibberd · Boston University Medical Campus · R01 · FY2024 · HD
Mechanisms -of Fc-dependent, broad-spectrum, humoral immunity against influenza
$508,017Jeffrey Victor Ravetch · Icahn School Of Medicine At Mount Sinai · U19 · FY2016 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$507,955Richard Rothman · Johns Hopkins University · N01 · FY2020 · AI
Metabolic alterations in age-associated dendritic cell dysfunction
$507,778Edith M Janssen · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · AG
Function and mechanism of the HCV p7 channel and its therapeutic potential
$507,639James J Chou · Harvard Medical School · R56 · FY2014 · AI
Vaccine immunogenicity and efficacy in the rhesus macaque/SHIV model
$507,591Ruth Margrit Ruprecht · University Of Louisiana At Lafayette · U19 · FY2021 · AI
Metabolic approaches to treat severe viral and inflammatory diseases
$507,085Augusto C Ochoa · Lsu Health Sciences Center · R01 · FY2013 · AI
Methods for Evaluating Vaccine Efficacy
$507,032M Elizabeth Halloran · Fred Hutchinson Cancer Research Center · R37 · FY2015 · AI
Methods for Evaluating Vaccine Efficacy
$507,032M Elizabeth Halloran · Fred Hutchinson Cancer Research Center · R37 · FY2014 · AI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$506,940Ann R Falsey · University Of Rochester · UM1 · FY2022 · AI
Immune Correlates for GM-CSF Mediated Enhancement of Vaccine Efficacy
$506,924Rama Rao Amara · Emory University · U19 · FY2014 · AI
Surveillance and health promotion informatics at work
$506,846Kenneth D Mandl · Boston Children'S Hospital · R01 · FY2006 · CD
Microchip for HBV testing using HIV-infected blood samples
$506,768Hadi Shafiee · Brigham And Women'S Hospital · R01 · FY2020 · AI
Loss of cellular identity after influenza virus infection and effects on pulmonary function
$506,729Nicholas S Heaton · Duke University · R01 · FY2018 · HL
Pulmonary Epithelial Dynamics and Innate Host Defense
$506,717Francis X McCormack · University Of Cincinnati · R01 · FY2018 · HL
Carbon nanotube integrated microdevice for next generation sequencing based virus discovery
$506,704Siyang Zheng · Carnegie-Mellon University · R01 · FY2019 · AI
Therapeutically harnessing anti-viral resident memory T cells in solid tumors
$506,676Pamela Rosato · Dartmouth College · R01 · FY2023 · CA
Electron Spin Relaxation in Model Membranes
$506,514Jack H Freed · Cornell University · R01 · FY2017 · GM